López-Mora DA - Search Results

1

The Added Value of Dynamic 18F-Florbetapir PET in the Assessment of Dementia With Lewy Bodies.

López-Mora DA, Camacho V, Lleó A, Fernández A, Carrió I. López-Mora DA, et al. Clin Nucl Med. 2018 Mar;43(3):e85-e86. doi: 10.1097/RLU.0000000000001952. Clin Nucl Med. 2018. PMID: 29261640

2

Value of ¹⁸F-FDG PET/CT in the diagnosis of chorea-acanthocytosis.

López-Mora DA, Camacho V, Fernandez A, Fuentes F, Pérez-Pérez J, Carrio I. López-Mora DA, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018 Sep-Oct;37(5):328-329. doi: 10.1016/j.remn.2017.11.002. Epub 2017 Dec 6. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2018. PMID: 29208484 English, Spanish. No abstract available.

3

Striking lack of visualization of striatum on ¹⁸F-FDG brain PET in chorea-acanthocytosis.

López-Mora DA, Camacho V, Fernández A, Granell E, Carrió I. López-Mora DA, et al. Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):511-512. doi: 10.1007/s00259-017-3905-z. Epub 2017 Dec 15. Eur J Nucl Med Mol Imaging. 2018. PMID: 29242959 No abstract available.

4

Selection of Reference Regions to Model Neurodegeneration in Huntington Disease by 18F-FDG PET/CT Using Imaging and Clinical Parameters.

López Mora DA, Sampedro F, Camacho V, Fernández A, Fuentes F, Duch J, Pérez-Perez J, Martínez-Horta S, Marín-Lahoz J, Domènech A, Flotats A, Estorch M, Kulisevsky J, Carrió I. López Mora DA, et al. Clin Nucl Med. 2019 Jan;44(1):e1-e5. doi: 10.1097/RLU.0000000000002329. Clin Nucl Med. 2019. PMID: 30325816

5

Striking neurologic 18F-FDG PET/CT pattern in Devic's disease (neuromyelitis optica spectrum disorder).

López-Mora DA, Flotats A, Fernández A, Sizova M, Camacho V, Carrió I. López-Mora DA, et al. Eur J Nucl Med Mol Imaging. 2020 Feb;47(2):511-512. doi: 10.1007/s00259-019-04549-4. Epub 2019 Nov 27. Eur J Nucl Med Mol Imaging. 2020. PMID: 31776629 No abstract available.

6

The Added Value of Tau-PET in the Assessment of Progressive Supranuclear Palsy.

López-Mora DA, Fernández León A, Lleó A, Blesa R, Camacho V. López-Mora DA, et al. Clin Nucl Med. 2020 May;45(5):e239-e240. doi: 10.1097/RLU.0000000000002977. Clin Nucl Med. 2020. PMID: 32149810

7

Digital PET vs Analog PET: Clinical Implications?

López-Mora DA, Carrió I, Flotats A. López-Mora DA, et al. Semin Nucl Med. 2022 May;52(3):302-311. doi: 10.1053/j.semnuclmed.2021.10.004. Epub 2021 Nov 24. Semin Nucl Med. 2022. PMID: 34836617 Review.

8

Audiovisual intervention alleviates anxiety of patients during PET/CT imaging.

Abouzian S, Camacho V, Sabaté A, Stefaneli P, Sizova M, Gich I, López-Mora D, Duch J, Fernández A, Estorch M, Carrió I, Flotats A. Abouzian S, et al. Nuklearmedizin. 2022 Aug;61(4):301-307. doi: 10.1055/a-1759-4062. Epub 2022 Aug 5. Nuklearmedizin. 2022. PMID: 35931063 English.

9

Use of PET/CT with ¹⁸F-FDG in the diagnosis of paraneoplastic limbic encephalitis.

Alarcón L, López-Mora D, Fernández A, Carrió I, Camacho V. Alarcón L, et al. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020 May-Jun;39(3):173-174. doi: 10.1016/j.remn.2019.10.001. Epub 2019 Dec 10. Rev Esp Med Nucl Imagen Mol (Engl Ed). 2020. PMID: 31836566 English, Spanish. No abstract available.

10

Striatal hypometabolism in premanifest and manifest Huntington's disease patients.

López-Mora DA, Camacho V, Pérez-Pérez J, Martínez-Horta S, Fernández A, Sampedro F, Montes A, Lozano-Martínez GA, Gómez-Anson B, Kulisevsky J, Carrió I. López-Mora DA, et al. Eur J Nucl Med Mol Imaging. 2016 Nov;43(12):2183-2189. doi: 10.1007/s00259-016-3445-y. Epub 2016 Jun 28. Eur J Nucl Med Mol Imaging. 2016. PMID: 27349245

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

35 results

Search Page